India’s healthcare in critical condition: 4 out of 5 public health centers below par, reveals new Govt report
In a recent self-assessment conducted by the Indian government, it has come to light that a vast majority of the country's public health facilities are...
Wockhardt aims to launch antibiotic with USD 25 bn mkt potential by early FY26
Drugmaker Wockhardt on Friday said research and trials on the antibiotic Zaynich are progressing satisfactorily, and it is aiming for an early FY26 launch. Zaynich...
Signs of breast cancer you must not ignore – New Lump
Jun 28, 2024, 05:24:33 PM ISTA new lump or mass in the breast or armpit is the most common symptom of breast cancer. The lump...
pharmaceutical manufacturing units: Risk-based audits of drug units to begin from July 1
The Drug Controller General of India (DCGI) Rajeev Raghuvanshi on Thursday said the risk-based inspections based on revised Schedule M of the Drugs and Cosmetics...
Nearly half of India not active enough, says Lancet; Why is it concerning? – Half of India physically inactive
Jun 27, 2024, 04:59:09 PM IST1/5Half of India physically inactiveAlmost 50 per cent of adults in India engaged in insufficient levels of physical activity in...
Norms soon on disposing of expired medicines
NEW DELHI: Throwing expired medicines with household trash is not an ideal way to get rid of them. The country's drug controller is working on...
Dr Reddy’s: Dr Reddy’s to buy nicotine replacement brands from UK-based Haleon for $632 million
Dr. Reddy’s Laboratories on Tuesday has entered into a definitive agreement to acquire consumer healthcare brands in the Nicotine Replacement Therapy (NRT) category outside of...
World’s first epilepsy device fitted in 13 year old UK boy’s skull; Here’s how the device works
A 13-year-old boy from England has made medical history as the first person in the world with severe epilepsy to trial a new device fitted...
Jubilant Pharmova’s US arm prepays Rs 626 crore term loan
Jubilant Pharmova on Tuesday said its wholly-owned US subsidiary has completed of $75 million ( Rs. 626 crore) term loan. As on March 31, 2024,...
Government considers ban on two antibiotics
New Delhi: The government is considering banning the production, import and distribution of the chloramphenicol and nitrofurans classes of antibiotics for use in any food-producing...